Stock Events

Abbott Laboratories 

$104.02
2817
+$1.72+1.68% Friday 20:00

統計

當日最高
104.07
當日最低
101.76
52週最高
121.04
52週最低
88.8
成交量
5,061,999
平均成交量
5,973,525
市值
180.96B
市盈率
32.3
股息收益率
2.11%
股息
2.2

即將到來

股息

2.11%股息收益率
10年增長
9.6%
5年增長率
11.44%
3年增長率
6.92%
1年增長率
7.84%

收益

18Jul確認
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
下一個
0.93
1.02
1.1
1.19
預期每股收益
1.106567
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 ABT 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

分析師評級

125.33$平均價格目標
最高估價為 $140。
來自過去 6 個月內的 6 個評級。這不是投資建議。
買入
100%
持有
0%
賣出
0%

關於

Health Technology
Medical Specialties
Manufacturing
Pharmaceutical Preparation Manufacturing
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Show more...
首席執行官
員工
114000
國家
US
ISIN
US0028241000
WKN
000850103

上市公司